Warner Chilcott PLC

Warner Chilcott — Merger or Acquisition (May 2013)

23 slides from Warner Chilcott's merger presentation, May 20, 2013

  1. Slide 1: Colleague Announcement Presentation

    [GRAPHIC OMITTED] Colleague Announcement Presentation May 20, 2013

  2. Slide 2: Combination of Actavis and Warner Chilcott

    Combination of Actavis and Warner Chilcott [GRAPHIC OMITTED] [] Today marks an important milestone for Warner Chilcott. Earlier this morning we announced that we have reached an agreement to enter into a combination with Actavis. The successful combination of our two companies will create an $11 bil

  3. Slide 3: What does this mean for you?

    What does this mean for you? [GRAPHIC OMITTED] Key Reminders [] Until the transaction closes we will continue to operate as separate companies. Between now and the day we close (anticipated to be by the end of 2013) and until notified otherwise: * Your role and day-to-day responsibilities remain the

  4. Slide 4: Protocols and Guidelines

    Protocols and Guidelines [GRAPHIC OMITTED] Prior to closing of the combination: [] The companies and their employees may not discuss or exchange confidential, competitively sensitive information such as plans, contract negotiations, rates, discounts, other customer terms or other sensitive business

  5. Slide 5: Third Party Communications Guidelines

    Third Party Communications Guidelines [GRAPHIC OMITTED] [] External Media / Press / Investors: * Please forward all inquires from local or international media/press and non- employees to Kevin Crissey, Director, Investor Relations (kevin. crissey@wcrx. com) at 973-907-7084. Please do not attempt to

  6. Slide 6: Sample Letter to Customers

    Sample Letter to Customers [GRAPHIC OMITTED] If you feel written communication notifying customers is necessary, the following text can be sent to customers later this week. Please refer to talking points if you are meeting with customers in person. Dear ___________________ : As I expect you have he

  7. Slide 7: Sample Talking Points for Customers

    Sample Talking Points for Customers [GRAPHIC OMITTED] * Use the following talking points when calling or meeting with doctors and customers. Remember to avoid speculation about the future. * On May 20, 2013, Actavis and Warner Chilcott announced that we have reached an agreement to combine the two c

  8. Slide 8: Next Steps

    Next Steps [GRAPHIC OMITTED] What can you expect in the coming days? [] We will continue to post FAQs on my. wcrx. com. [] Visit www. ourwinningway. com for more information on Actavis [] Submit your questions about the announcement to the Warner Chilcott Corporate Human Resources mailbox (Corporate

  9. Slide 9: Questions and Answers

    Questions and Answers [GRAPHIC OMITTED] [GRAPHIC OMITTED] 9

  10. Slide 10: Additional Info On Actavis

    [GRAPHIC OMITTED] Additional Info On Actavis 10

  11. Slide 11: Creating an ~$11 Billion Global Pharmaceutical Company

    [GRAPHIC OMITTED] Creating an ~$11 Billion Global Pharmaceutical Company Creating a ~$3 Billion Specialty Brand Pharmaceutical Company [GRAPHIC OMITTED] [GRAPHIC OMITTED]

  12. Slide 12: Achieving a Top Position

    [GRAPHIC OMITTED] Achieving a Top 3 Position [GRAPHIC OMITTED] Strong Growth Potential * $3 billion Actavis Specialty Brands 2013 PF Revenues * Combination will augment Actavis' core areas of Women's Health and Urology * Premier Women's Health player in US * Larger Portfolio in Urology * Warner Chil

  13. Slide 13: Actavis Corporate Culture - Our Winning Way

    [GRAPHIC OMITTED] Actavis Corporate Culture - Our Winning Way [GRAPHIC OMITTED]

  14. Slide 14: Actavis Executive Leadership Team

    [GRAPHIC OMITTED] Actavis Executive Leadership Team [GRAPHIC OMITTED]

  15. Slide 15: Actavis Industry-Leading Global Supply Chain

    [GRAPHIC OMITTED] Actavis Industry -Leading Global Supply Chain [GRAPHIC OMITTED]

  16. Slide 16: Actavis Global R&D Capabilities and Assets

    [GRAPHIC OMITTED] Actavis Global RandD Capabilities and Assets IR Oral Solids MR Oral Solids Patch/Topicals Injectables [] India [] Florida, USA [] Utah, USA [] Italy [] Iceland [] New Jersey, USA [] Maryland, USA [] Romania [] Bulgaria [] Bulgaria Others [] Lotus BE and CE studies, India [] Inhalat

  17. Slide 17: Actavis U.S. Generics Team

    [GRAPHIC OMITTED] Actavis U.S. Generics Team Claims Number 1 in Revenues Based on Q1 '13 Financial Results [GRAPHIC OMITTED] [GRAPHIC OMITTED] [GRAPHIC OMITTED]

  18. Slide 18: Actavis Specialty Brands: Group Overview

    [GRAPHIC OMITTED] Actavis Specialty Brands: Group Overview [] 40+ U. S. brand products - Urology and Women's Health [] ~100 scientists in RandD [] ~430 person U. S. sales team - Target Urologists and OB/Gyns [] 24 person Canada sales team - Target Urologists and PCPs [GRAPHIC OMITTED]

  19. Slide 19: Actavis Specialty Brands: U.S. Brands Business

    [GRAPHIC OMITTED] Actavis Specialty Brands: U.S. Brands Business [] Therapeutic Categories -- Benign Prostate Hyperplasia (BPH) -- Testosterone Replacement -- Prostate Cancer -- Over Active Bladder (OAB) -- Iron Deficiency -- Contraceptives -- Infertility -- Hormone Replacement [GRAPHIC OMITTED]

  20. Slide 20: Stronger Combined Specialty Brands Portfolio

    [GRAPHIC OMITTED] Stronger Combined Specialty Brands Portfolio [GRAPHIC OMITTED] Women's Health Urology GI and Dermatology [GRAPHIC OMITTED]

  21. Slide 21: Important Information for Investors and Shareholders

    [GRAPHIC OMITTED] Important Information for Investors and Shareholders [] This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. New Actavis will file with the Securities and Exchange Commission (the "S

  22. Slide 22: Warner Chilcott Cautionary Statement Regarding Forward-Looking Statements

    [GRAPHIC OMITTED] Warner Chilcott Cautionary Statement Regarding Forward -Looking Statements This communication contains forward-looking statements, including statements concerning the proposed transaction with Actavis, our industry, our operations, our anticipated financial performance and financia

  23. Slide 23: Statement Required by the Irish Takeover Rules

    [GRAPHIC OMITTED] Statement Required by the Irish Takeover Rules [] The directors of Warner Chilcott accept responsibility for the information contained in this announcement. To the best of the knowledge and belief of the directors of Warner Chilcott (who have taken all reasonable care to ensure suc

Warner Chilcott — Merger or Acquisition (May 2013) on 6ix